We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Dingell, Stupak Investigating Vytorin Clinical Trial
Reps. John Dingell (D-Mich.) and Bart Stupak (D-Mich.) asked Merck and Schering-Plough to explain their delay in releasing data from a clinical trial of the cholesterol drug Vytorin.